Use and abuse of placebo in phase III trials
- PMID: 9626912
- DOI: 10.1007/s002280050429
Use and abuse of placebo in phase III trials
Similar articles
-
Placebo surgery for Parkinson's disease: do the benefits outweigh the risks?J Law Med Ethics. 2002 Spring;30(1):58-68. doi: 10.1111/j.1748-720x.2002.tb00720.x. J Law Med Ethics. 2002. PMID: 11905269 No abstract available.
-
Placebo-controlled studies in rheumatoid arthritis: ethical issues.Lancet. 1999 Jan 30;353(9150):400-3. doi: 10.1016/S0140-6736(98)01373-7. Lancet. 1999. PMID: 9950461 Review. No abstract available.
-
Confusion over use of placebos in clinical trials.BMJ. 1995 Sep 30;311(7009):821-2. doi: 10.1136/bmj.311.7009.821. BMJ. 1995. PMID: 7580477 Free PMC article. No abstract available.
-
Placebo mania. Placebos are essential when extent and variability of placebo response are unknown.BMJ. 1996 Oct 19;313(7063):1008. doi: 10.1136/bmj.313.7063.1008a. BMJ. 1996. PMID: 8892441 Free PMC article. No abstract available.
-
Placebos in clinical practice and research.J Med Ethics. 1996 Jun;22(3):140-6. doi: 10.1136/jme.22.3.140. J Med Ethics. 1996. PMID: 8798935 Free PMC article. Review.
Cited by
-
Can keeping clinical trial participants blind to their study treatment adversely affect subsequent care?Contemp Clin Trials. 2005 Jun;26(3):290-9. doi: 10.1016/j.cct.2005.01.003. Epub 2005 Mar 3. Contemp Clin Trials. 2005. PMID: 15911463 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources